Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...
The approval was supported by data from the ongoing Phase III MajesTEC-3 study.
What Is Darzalex Faspro, and Why Does It Matter? Darzalex Faspro is a medicine used to treat adults with multiple myeloma, a type of blood cancer, and amyloidosis, a rare condition where abnormal ...
Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...
Richardson, MD, gave an overview of the ways that CELMoDs are poised to impact the landscape of multiple myeloma treatment at various stages of disease treatment. At the Miami Cancer Institute’s ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) announced that the U.S. Food and Drug Administration has approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as the first-ever treatment for ...
Explore the latest advancements in myeloma treatment, emphasizing quadruplet therapy and the significance of specialist care for optimal patient outcomes. In the evolving landscape of multiple myeloma ...
Adding teclistamab to daratumumab dramatically improved progression-free survival and overall survival vs standard-of-care (SOC) therapy in patients with relapsed or refractory multiple myeloma (RRMM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results